| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104 [O. A. H., K. O., S. K. G., T. G. O.]; The Lankenau Medical Research Center, Philadelphia, Pennsylvania 19151 [K. Y. Y., J. P., C. P. H., I. K., G. A. R.]; and Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 [S. L.]
Ornithine decarboxylase (ODC) activity was measured in colon adenocarcinomas and adjacent normal-appearing colon mucosa from a total of 40 patients undergoing surgical resections. The enzyme activity was measured in the presence and absence of GTP, since recent work has demonstrated a GTP-activatable form of ODC in some murine and human tumors. In general, ODC specific activity was higher in adenocarcinomas than in adjacent normal-appearing mucosa. Of greater interest, however, was the finding that 13 of 40 tumors and 3 of 40 mucosae contained a GTP-activatable form of ODC. These are minimal estimates of the proportion of tissues positive for this enzyme form, since a multiple sampling protocol indicated that expression of a GTP-activatable ODC was not uniform throughout a given tumor. Chromatographic analyses of tumor extracts revealed the presence in some tumors of multiple size forms of ODC, only some of which were activated by GTP. Enzyme kinetic data indicated that the multiple forms of ODC can have different affinities for L-ornithine and that GTP can "normalize" the aberrant kinetic properties of these forms.
While there was no statistically significant correlation of the presence of a GTP-activatable ODC with stage of disease, analysis of our data revealed a positive association of a GTP-activatable ODC with tumor site; a much higher percentage of tumors of the cecum contained this ODC isoform than tumors of other colonic segments (64% versus
25% for other sites). These results demonstrate (a) the presence of a functionally distinct form of ODC in some human colon adenocarcinomas and (b) a distinct regional distribution of this ODC form within the colon. We suggest this alteration in a key enzyme in the growth-associated pathway of polyamine biosynthesis may play a role in colon tumor progression.
1 This work was supported by NIH Grants ES-01664, CA-06927, and RR-05539, a grant from the Mary L. Smith Charitable Lead Trust, and an appropriation from the Commonwealth of Pennsylvania.
2 To whom requests for reprints should be addressed, at The Wistar Institute of Anatomy and Biology, 36th Street at Spruce, Philadelphia, PA 19104.
Received 8/ 4/89.
Revised 12/ 4/89.
This article has been cited by other articles:
![]() |
C. A. Hobbs, G. Wei, K. DeFeo, B. Paul, C. S. Hayes, and S. K. Gilmour Tip60 Protein Isoforms and Altered Function in Skin and Tumors that Overexpress Ornithine Decarboxylase Cancer Res., August 15, 2006; 66(16): 8116 - 8122. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Y. Chen, J.-L. Shie, and C.-C. Tseng Gut-enriched Kruppel-like Factor Represses Ornithine Decarboxylase Gene Expression and Functions as Checkpoint Regulator in Colonic Cancer Cells J. Biol. Chem., November 22, 2002; 277(48): 46831 - 46839. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Mafune, Y. Tanaka, K. Mimori, M. Mori, K. Takubo, and M. Makuuchi Increased Expression of Ornithine Decarboxylase Messenger RNA in Human Esophageal Carcinoma Clin. Cancer Res., December 1, 1999; 5(12): 4073 - 4078. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |